BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20842231)

  • 1. Vitamin D in combination cancer treatment.
    Ma Y; Trump DL; Johnson CS
    J Cancer; 2010 Jul; 1():101-7. PubMed ID: 20842231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
    Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
    Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor activity of calcitriol: pre-clinical and clinical studies.
    Trump DL; Hershberger PA; Bernardi RJ; Ahmed S; Muindi J; Fakih M; Yu WD; Johnson CS
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):519-26. PubMed ID: 15225831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D-related therapies in prostate cancer.
    Johnson CS; Hershberger PA; Trump DL
    Cancer Metastasis Rev; 2002; 21(2):147-58. PubMed ID: 12465754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor: a potential target for intervention.
    Johnson CS; Hershberger PA; Bernardi RJ; Mcguire TF; Trump DL
    Urology; 2002 Sep; 60(3 Suppl 1):123-30; discussion 130-1. PubMed ID: 12231068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of calcitriol in cancer prevention and treatment.
    Ma J; Ma Z; Li W; Ma Q; Guo J; Hu A; Li R; Wang F; Han S
    Curr Med Chem; 2013; 20(33):4121-30. PubMed ID: 23895685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitriol in cancer treatment: from the lab to the clinic.
    Beer TM; Myrthue A
    Mol Cancer Ther; 2004 Mar; 3(3):373-81. PubMed ID: 15026558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
    Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
    Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of weekly high-dose calcitriol based therapy for prostate cancer.
    Beer TM
    Urol Oncol; 2003; 21(5):399-405. PubMed ID: 14670552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
    Wietrzyk J; Milczarek M; Kutner A
    Oncol Res; 2007; 16(11):517-25. PubMed ID: 18306931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.
    Peehl DM; Seto E; Hsu JY; Feldman D
    J Urol; 2002 Oct; 168(4 Pt 1):1583-8. PubMed ID: 12352462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.
    Flynn G; Chung I; Yu WD; Romano M; Modzelewski RA; Johnson CS; Trump DL
    Oncology; 2006; 70(6):447-57. PubMed ID: 17237620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
    Smith DC; Johnson CS; Freeman CC; Muindi J; Wilson JW; Trump DL
    Clin Cancer Res; 1999 Jun; 5(6):1339-45. PubMed ID: 10389917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative role of vitamin D and its analogs--a brief overview.
    Banerjee P; Chatterjee M
    Mol Cell Biochem; 2003 Nov; 253(1-2):247-54. PubMed ID: 14619976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol in the treatment of prostate cancer.
    Beer TM; Myrthue A
    Anticancer Res; 2006; 26(4A):2647-51. PubMed ID: 16886675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
    Krishnan AV; Feldman D
    Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for the development and current status of calcitriol in androgen-independent prostate cancer.
    Beer TM; Myrthue A; Eilers KM
    World J Urol; 2005 Feb; 23(1):28-32. PubMed ID: 15668801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma.
    Satake K; Takagi E; Ishii A; Kato Y; Imagawa Y; Kimura Y; Tsukuda M
    Auris Nasus Larynx; 2003 Dec; 30(4):403-12. PubMed ID: 14656567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent strategies for the use of paclitaxel in the treatment of urological malignancies.
    Bokemeyer C; Hartmann JT; Kuczyk MA; Truss MC; Kollmannsberger C; Beyer J; Jonas U; Kanz L
    World J Urol; 1998; 16(2):155-62. PubMed ID: 12073232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitriol Combined With Platinum-based Chemotherapy Suppresses Growth and Expression of Vascular Endothelial Growth Factor of SKOV-3 Ovarian Cancer Cells.
    Kim JH; Park WH; Suh DH; Kim K; No JH; Kim YB
    Anticancer Res; 2021 Jun; 41(6):2945-2952. PubMed ID: 34083285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.